The Motley Fool Previous Page

Why Rigel Pharmaceuticals, Inc. Shares Popped

Alex Planes
March 6, 2014

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Rigel Pharmaceuticals (NASDAQ: RIGL) are trading about 9% higher this afternoon after topping out at a 15% gain in the morning following the company's publication of research results for R118.

So what: The results for studies with Rigel's R118, an orally bioavailable AMPK (AMP-activated protein kinase) activator, were published in the American Journal of Physiology